Marshall Mohr - Oct 25, 2021 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Executive VP & CFO
Signature
By: Donna Spinola For: Marhall L. Mohr
Stock symbol
ISRG
Transactions as of
Oct 25, 2021
Transactions value $
-$5,732,433
Form type
4
Date filed
10/26/2021, 05:10 PM
Previous filing
Aug 27, 2021
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $1.21M +20.5K $59.23* 20.5K Oct 25, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$6.95M -20.5K -100% $339.20 0 Oct 25, 2021 Direct F1, F2, F3
holding ISRG Common Stock 95.7K Oct 25, 2021 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -20.5K -100% $0.00* 0 Oct 25, 2021 Common Stock 20.5K $59.23 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 2, 2021.
F2 On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $336.76 to $341.66 as follows: 200 shares sold at $336.76 to $336.77; 2,392 shares sold at $337.03 to $337.96; 12,570 shares sold at $338.02 to $339.99; 4,423 shares sold at $$340.03 to $340.89; 890 shares sold at $$341.015 to $341.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48th one month after the date of grant and 1/48th monthly thereafter.